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“Caballo”: risk environments, drug sharing 
and the emergence of a hepatitis C virus 
epidemic among people who inject drugs 
in Puerto Rico
R. Abadie1*  and K. Dombrowski2
Abstract 
Background: Sharing drug injection equipment has been associated with the transmission of HCV among PWID 
through blood contained in the cooker and cotton used to prepare and divide up the drug solution. While epidemi-
ologists often subsume this practice under the sharing of “ancillary equipment,” more attention should be paid to the 
fact that indirect sharing takes place within the process of joint drug acquisition and preparation.
Methods: We employed an ethnographic approach observing active PWID (N = 33) in four rural towns in Puerto Rico 
in order to document drug sharing arrangements involved in “caballo”, as this practice is locally known. We explored 
partners’ motivation to engage in drug sharing, as well as its social organization, social roles and existing norms.
Findings: Findings suggest that drug sharing, is one of the main drivers of the HCV epidemic in this population. Lack 
of financial resources, drug packaging, drug of choice and the desire to avoid the painful effects of heroin withdrawal 
motivates participants’ decision to partner with somebody else, sharing injection equipment—and risk—in the pro-
cess. Roles are not fixed, changing not only according to caballo partners, but also, power dynamics.
Conclusion: In order to curb the HCV epidemic, harm reduction policies should recognize the particular sociocul-
tural contexts in which people inject drugs and make decisions about risk. Avoiding sharing of injection equipment 
within an arrangement between PWID to acquire and use drugs is more complex than assumed by harm reduction 
interventions. Moving beyond individual risk behaviors, a risk environment approach suggest that poverty, and a strict 
drug policy that encourage users to carry small amounts of illicit substances, and a lack of HCV treatment among 
other factors, contribute to HCV transmission.
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Background
While HCV-related deaths in the United States seem to 
have declined recently [1], research suggests the existence 
of an emerging hepatitis C virus (HCV) epidemic among 
people who inject drugs (PWID) in non-urban areas [2], 
which is likely associated with the transition from oral 
prescription opioid use to injection and often with the 
transition from prescription opioids to heroin [3]. Rates 
of HIV and HCV among PWID are on a divergent trajec-
tory. HIV prevalence has been declining for almost a dec-
ade, while HCV has increased over the same period [4].
Nowhere in the United States are these trends more 
prevalent than in Puerto Rico, a US territory, where 
recent epidemiological data suggest epidemic levels of 
HCV among PWID, with 89% prevalence in metropolitan 
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San Juan and 78.4% in rural areas [5, 6]. In the US, HCV 
prevalence among PWID ranks highest in Puerto Rico, at 
a similar level as the worst cases in the global south [7, 8].
Epidemiological studies of HCV transmission routes 
among PWID show that the virus can be transmitted not 
only though blood contained in shared syringes but also 
by sharing the cooker and cotton used to prepare the drug 
solution [9–11]. Yet, epidemiologists often misunder-
stand the dynamics of HCV transmission among PWID, 
subsuming the common use of a cooker, or a filtering cot-
ton ball, as the shared use of “ancillary equipment” [12, 
13]. As social scientists have noted, equipment sharing is 
often a proxy for preparing and dividing drugs [14, 15]. 
Based on a study of PWID in Colorado, Koester (2005) 
suggests that indirect sharing, which happens when pow-
der drugs are diluted in water before been divided up in 
a cooker with the help of a syringe, is an efficient way 
of distributing drugs among injection partners. Using 
the calibration on the syringe barrel allows participants 
to compare the syringe contents’, effectively ensuring 
an equitable distribution. This type of indirect sharing 
which happens more often than direct syringe sharing, 
when one syringe is shared from one user to another [16] 
(Friedman et  al. 1997) has been found to be a common 
feature among PWID in a variety of social contexts [17–
24]. In a social network study of PWID in Brooklyn, New 
York Curtis and colleagues (1995) found that indirect 
sharing is extensively practiced within a network particu-
lar social networks, contributing to define a user posi-
tion in it. Those that engage in drug sharing often, are the 
“regulars” or insiders who are placed at the center of the 
network, while those that do engage occasionally some-
times coming from other neighborhoods or sporadically 
over the weekends, tend to occupy a peripheric position 
[25]. A similar study by Zule with PWID in San Antonio 
shows that participants drug sharing arrangements are 
asymetric relationships, with the person that provides the 
drug in a position to direct drug preparation and the per-
son receiving the drug solution unable to avoid the indi-
rect sharing of injection equipment [26].
A qualitative study of PWID in Tajikistan shows that 
while few users report direct syringe sharing, joint drug 
acquisition and preparation is common, particularly in 
outdoor settings or if participants experience withdrawal 
symptoms [27]. Another study in Viet Nam shows that 
drug sharing practices are driven by heroin price and 
accessibility as well as a punitive approach to drug use 
that penalizes drug possession [28].
In a multi-year study of Puerto Rican PWID in New 
York City and Bayamon, in San Juan found that, recent 
migrants from the island exhibit a much higher fre-
quency of indirect drug sharing than native users [29]. An 
ethnographic study conducted among PWID in San Juan 
extends these observations by exploring the motivations 
and social roles involved in drug sharing arrangements 
[30]. Finlinson (2011) shows that the price and packag-
ing of drugs and access to drug preparation materials 
along with power differences among partners shape the 
process by which drugs are prepared and injected. Other 
ethnographic studies demonstrated that drug sharing is 
facilitated by the type of heroin available. For example, 
Bourgois documents how homeless PWID in San Fran-
cisco use “black tar,” a sticky variety of heroin, originat-
ing in Mexico, that is extremely hard to divide up without 
preparing it, which, in turn, encourages the sharing of 
injection equipment [31, 32].
Departing from epidemiological views that focus on 
individual behaviors, these authors make a valuable 
contribution to the understanding of HCV risk among 
PWID by showing how particular social contexts, from 
the ways in which drugs are acquired, to social roles, cul-
tural norms, drug policies and power dynamics among 
those involved in “caballo” shape HCV risk. These find-
ings complicate traditional epidemiological views shap-
ing harm reduction initiatives, suggesting that forms of 
indirect sharing within the process of jointly acquiring 
and using drugs, are not easily modified by knowledge 
about HCV transmission, or the access to new injection 
equipment alone. As critics have suggested, the focus on 
individual behaviors at the expense of local social con-
texts in which PWID live and make decisions about risk, 
might obscure how social, structural and environmental 
contexts shape drug use and related harms [33–37].
Nested within a study of social networks and HIV/
HCV risk among PWID in rural Puerto Rico, we pro-
pose an ethnographically informed approach to “caballo”, 
the joint acquisition and sharing of drugs, as a window 
into the social production of an HCV epidemic among 
PWID. While drug sharing arrangements among PWID 
have been amply documented, an ethnographic study 
of caballo in Puerto Rico will illuminate the social con-
text behind the joint acquisition and use of drugs and its 
related epidemiological risk.
Methods
This paper utilizes ethnographic data from PWID 
recruited into a multi-phase study of social networks 
and HIV/HCV risk in four rural towns in the moun-
tainous area of central Puerto Rico. In the first phase of 
this study we collected demographic and sociometric 
data on PWID in rural Puerto Rico, as well as informa-
tion on injection behaviors, particularly on the sharing 
of syringes and injection equipment. In addition, rapid 
blood testing for HIV and HCV were conducted using 
INSTI Rapid HIV antibody tests (Biolytical Laboratories) 
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and OraQuick HCV Rapid antibody tests (OraSure 
Technologies).
It was during the administration of a National Health 
Behavioral Survey (NHBS) questionnaire [38] that we 
learned for the first time about “caballo”. Consistently, we 
heard from participants that while they carried their own 
syringe and avoided sharing it with others, they could 
not avoid using the same cooker within the process of 
drug sharing. Participants described the ways in which 
they divided up the drug solution in the cooker, using a 
backloading method to distribute it among partners. All 
participants insisted that they “always used their own 
cooker” during the preparation. Of course, since there are 
two or more caballo partners and only one cooker avail-
able, this was not possible. After this phase of data collec-
tion, we were left with many questions about the social 
organization and the meaning of drug sharing among this 
population.
To explore these issues, we conducted an ethnographic 
study with (N = 33) participants randomly recruited 
from the first phase. During the participant observation, 
each participant was followed -with their consent- for 
up to two weeks, documenting practices related to joint 
drug acquisition and use. Yet, our ethnographic obser-
vations were broadly constructed, focusing not only on 
drug sharing practices, but in describing their everyday 
lives and the strategies they used in order to afford their 
drugs of choice. For example, we had ample opportunity 
to observe participants’ hustling, in car washes, or guard-
ing a parking lot, or begging at the entrance of banks 
or dollar stores or other venues with heavy foot traf-
fic. After partnering with El Punto en la Montana, the 
only Syringe Exchange Provider in the area, we earned 
participants’ trust and were allowed to join them at the 
“chutin” a Spanglish deformation of shooting gallery. In 
so doing, we were able to collect data on their drug shar-
ing practices. We paid particular attention to the ways in 
which caballo partners talked about acquiring and shar-
ing drugs in an attempt to convey the norms or hidden 
scripts regulating caballo arrangements. In addition, we 
conducted in depth interviews to understand how PWID 
in our study described the social practice of “caballo”, the 
joint acquisition and later use of drugs. Some of the ques-
tions we posed were what is caballo, when do participants 
do it and with whom. We used our initial observations to 
iteratively refine our research questions. Since we had 
observed during the course of the ethnographic data col-
lection that sometimes arguments emerge during caballo, 
we asked participants about potential problems or con-
flicts associated with this practice and we also inquired 
about participants’ views on drug sharing related HCV 
risk and their perceived ability to enact changes to pre-
vent its transmission.
One limitation of our data collection is that for secu-
rity reasons, ethnographic observations were conducted 
during the day and until dusk and only during working 
days. Abandoned and dilapidated houses without elec-
tricity, shooting galleries are seldom used at night but are 
more used early in the day -as soon as drug selling spots 
are open- and on weekends when “regulars’ are joined 
by more occasional users. Despite the limits imposed by 
fieldwork dynamics we believe that our observations of 
caballo and the social context in which it occurs were not 
affected by these constraints.
Fieldnotes were transcribed while in-depth interviews 
were transcribed and translated. All personal identifi-
ers were removed. MAXQDA software was employed 
to manage coding. Codes were developed to convey the 
wide arrange of themes in the data set: caballo, drug 
acquisition, motivations, social roles, norms and expec-
tations and injection setting, among others. These codes 
were then iteratively revised and re-organized until they 
represented higher-level axial codes describing partici-
pants’ caballo experiences [39, 40]. Following Strauss’ 
grounded theory approach [41] (Strauss and Corbin 
1998) the interpretation of the data emerged intuitively 
without imposing a pre-existing theoretical framework.
The study received IRB approval through the (omit-
ted due to blind review) and the (omitted due to blind 
review). Participants provided written consent at the 
study office prior to enrollment in the study and were 
compensated for their time and travel expenses.
Findings
Participants’ sociodemographic background (Table 1).
Participants had a mean age of 44.15 years and the sam-
ple had a standard deviation of 9.2 years. The sample is 
overwhelmingly male (87.8%) and heterosexual (96.97%). 
Three-quarters were unemployed at the time, and almost 
one-half lived in poverty and had completed high school 
or a higher educational level. One in five were mar-
ried or living together and the same number had been 
homeless during the past year. Almost all participants 
(90.91%) were currently covered by health insurance, 
with a large majority having “La Reforma,” the local ver-
sion of Medicare/Medicaid. Around one in six (15.15%) 
had participated in a drug treatment program but only 
one participant had enrolled during the past year. Par-
ticipants had been injecting for a mean of 22.91  years 
with a standard deviation of 10.54. Age at first injection 
is 22.27 years with a standard deviation of 7.97. Almost 
four out of ten reported injecting two or three times a 
day while one in three injected four times or more a day. 
While HIV prevalence in this population is extremely low 
(3.03%), HCV prevalence reaches epidemic levels, with 
almost nine out of ten study participants testing positive 
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reactive for the virus (84.8%). Less than one in ten (7.14%) 
declared having used a syringe after somebody else had 
used it the last time they injected with somebody, and a 
large majority (84.6%) admitted using a sterile syringe. 
Almost three-quarters (71.43%) used a cooker, cotton, or 
water that somebody had previously used, while one in 
three (32.14%) divided drugs with a syringe that had been 
previously used by somebody else.
Caballo and the social production of an HCV 
epidemic
In rural Puerto Rico, two or more PWID often pool 
funds necessary to acquire and later share drugs. Most 
participants in our study have as a drug of choice heroin 
“droga” and cocaine “perico”, “speedball”. Speedballs have 
more heroin than cocaine, a usual way in which partici-
pants talk about their drug mix is by identifying it by the 
ratio of heroin to cocaine. For example, they would say 
“1–2” meaning one bag of cocaine and two of heroin. 
Other users might prefer three bags of heroin and one of 
cocaine “1–3”. In turn, this preference is also reflected in 
drug sharing arrangements. The drugs are mixed together 
in a cooker dissolved in water, and the resulting drug 
solution is shared usually through backloading, removing 
the plunger in a syringe and squirting the content using 
the tip of the needle of a loaded syringe, before placing it 
back. This practice is locally known as “caballo” (literally, 
horse). Participants do not recall the origin of the name, 
“caballo” but suggest that the same expression is used on 
the island in  situations where people pool resources to 
acquire and later consume goods together, usually food 
but also transportation. An ethnographic fieldnote taken 
at the shooting gallery a few blocks away from where 
our office was located, describes two study participants, 
Pablito and Cesar Cayey engaging in a “caballo”:
Pablito and Cesar had bought their drugs of choice at 
the one of the local “Puntos”, the drug selling spot, only 
a few blocks away from the dilapidated house that served 
as shooting gallery. They briefly discussed how the drugs 
would be divided up agreeing that since they had con-
tributed the same amount of money, each would receive 
equal parts of the drug solution. However, since Pablito, 
was helping Cesar inject because his partner was unable 
to find his own veins, Pablito would be in charge of the 
preparation.
The cooker, a small sized tin cup provided by the local 
Syringe Exchange Provider, El Punto en la Montana and 
a plastic water bottle were laid out on the cement floor by 
Pablito, who was in charge of the preparation. The plastic 
clear blue bag containing cocaine was opened and placed 
carefully on the cooker along with the contents of three 
colored metallic paper envelopes with heroin. Water 
Table 1 Descriptive statistics
Mean/% SD N
Age (years) 44.15 9.12 33
% Male 87.88% 33
% Heterosexual 96.97% 33
% Unemployed 75.75% 33
% Experienced homelessness in past year 21.21% 33
% Graduate high school (or higher) 54.55% 33
% Married or living together as married 21.24% 33
% Annual income < $5000 51.52% 33
Average money spent on drugs daily $41 $24.45 33
% Currently covered by health insurance 90.91% 33
% Ever participated in a drug treatment program 15.15% 33
Number of years injecting 20.91 10.54 33
Age at first injection 22.27 7.97 33
% Injected 4 or more times per day 30.30% 33
% Injected 2–3 times per day 39.39% 33
% Tested positive for HIV 3.03% 33
% Tested positive for HCV 84.84% 33
Last time you injected with someone did you…
Use a needle after someone else 7.14% 28
Use a sterile needle 84.62% 26
Use a cooker, water, or cotton that someone else had used 71.43% 28
Use drugs that had been divided with a syringe that someone else had used 32.14% 28
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from a plastic bottle was loaded into a syringe and then 
discharged into the cooker. The content was then mixed 
with the back of a syringe making sure it was completely 
diluted. Although the cocaine is a white powder and the 
heroin a light brown, grey or creamy color, when mixed 
with water, the solution turned into a brown color.
Without heating—it is believed to “eat up” the drug 
because when heated some of the content evaporates 
leaving a more powerful concentration, but less quantity-
Pablito skillfully “recogio” or loaded the preparation with 
the help of a syringe with its needle inserted into a small 
cotton ball no larger than the head of a match to filter any 
impurities. With the syringe “full”, half of its content was 
then “echado” distributed into Cesar’s syringe by remov-
ing the plunger on the back. After verifying that both 
syringes had exactly the same amount by holding them 
side by side, using the lines on the side of the syringes as 
a guide, the plunger in Cesar’s syringe was placed back. 
Both syringes were now, half full, having divided a loaded 
syringe used to divide drugs up, in two equal parts.
Far from a ritual practice to strengthen a bond between 
injection partners, caballo seems to be a consciously 
made strategic decision to maximize drug access among 
PWID. Drugs are jointly acquired and then divided up 
among pooling partners. The most common arrange-
ment is to distribute the drug solution according to the 
monetary contributions of each member proportion-
ally. Partners can share drugs at “brazo partido” a local 
expression translated as half and half, or 50%-50%, if 
they contributed equally, although it is possible that the 
partner that contributes the most agrees to divide drugs 
equally, particularly if they have a long-standing relation-
ship with the caballo partner.
Josephine, a 34-year-old woman who started injecting 
in her teens, provides a description of the advantages of 
this practice: “Look, let’s suppose that I want to use two 
and one [two bags of heroin and one bag of cocaine] and 
that you have $5 and I have $10. So, I ask you, Julio, ‘Do 
you have $5?’ ‘Yes,’ [you respond].[I say,] ‘Great! Let’s do 
two and one, you put in those $5 for the perico [cocaine] 
and I put [in for] the heroin.’ We put everything together 
in the cooker, and then we divide it in the syringe, half 
and half, and we get cured. That’s it.”
While most PWID in the study would prefer to avoid 
caballo if they could, particularly, for high frequency 
users, the economic demands make it extremely hard to 
go during the day without partnering with another user 
to acquire and use drugs. With a large proportion in 
unemployment, receiving meager social security checks, 
working at the lower levels of the local drug trade, or 
engaging in side hustles, it becomes extremely difficult 
for PWID in our area to secure the whole amount every 
time they need to inject. Opioid users dread the painful 
effects of heroin withdrawal, or what they call “being 
sick,” characterized by bodily pain and discomfort, nau-
sea, coldness, shivers, and diarrhea that leave them “una-
ble to function.” Only “la cura”, the cure, another dose 
of heroin, would stop or prevent these symptoms form 
occurring. Faced with limited resources to “get cured” 
the user has to make a choice between partnering with 
somebody in a caballo or going it alone and hustling until 
they can afford the whole dose they need. Entering into a 
caballo arrangement, enables them to feel normal again, 
while they can keep hustling to get their next dose. While 
the rewards of going alone might be higher because par-
ticipants get their full dose, so are the associated costs 
because users have to battle their withdrawal symptoms 
while they come up with the money. And the longer it 
takes for participants to secure the resources to afford 
their dose, the worst their withdrawal symptoms become, 
offering a powerful incentive to enter into a drug sharing 
agreement with another user.
To avoid heroin withdrawal, if possible, caballo part-
ners prefer to acquire their drug of choice in a Punto 
close to where they can use it, without delay. But in rela-
tively small rural locations, drug choices are restricted, 
particularly in relation to package size. Locally, heroin 
can be bought in bags of five or ten dollars and cocaine 
comes in “cinquillos” fives, or $5, but if caballo partners 
can get a hold on a car, they usually pool up $2 or $3 each 
for gas and head to nearby Caguas o San Juan where bags 
cost the same but are two or up to three times larger. This 
drug packaging makes the trip worthwhile, even consid-
ering the gasoline costs and that time spent on the hour 
round trip could have been used “revuleando”, hustling, 
at home.
The frequency of caballo changes from participant to 
participant; some engage in caballo almost every time 
they use, while others do it less frequently. Since caballo 
partners tend to inject smaller drug amounts, they also 
need to engage in this practice more often. Speedball also 
provides more opportunities to share drugs because one 
partner might have cocaine but not heroin, while other 
might be in the opposite situation, in this situation, one 
solution is pooling resources and then dividing up the 
drug solution.
PWID in our study declared that they prefer not to do 
caballo for their first dose of the day, as it would signifi-
cantly decrease the amount of heroin received and thus 
stave off withdrawal symptoms for a shorter amount of 
time. Walter, a 48-year-old user who injects two or three 
times a day, explains this choice with the use of a meta-
phor: “It’s like pizza: if you eat two pieces you are going 
to feel full but if you eat only one, or just a bite, you will 
feel hungrier sooner.” However, here economic consider-
ations play a role. If access to a sufficient dose to prevent 
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the onset of withdrawal symptoms is not available, users 
might resort to caballo early in the day. Those who have 
been successful in securing their own first dose might 
decide to engage in caballo later in the day in order to 
maximize resources, and can afford to engage in the 
practice more selectively. Caballo is also affected by a 
particularly punitive version of the war on drugs adopted 
by the Island since the 1980′s. Most of our study partici-
pants have been jailed at least once in their lifetime, often 
for non-violent drug offences [42]. Having no more than 
a few bags can lead to heavy prison sentences under the 
“possession with intent” to distribute charges. To avoid 
problems, PWID tend to carry small drug amounts with 
them, which, in turn, encourages drug sharing.
Caballo can be structured along defined social roles, 
with important epidemiological repercussions. A pri-
mary partner directs the preparation and distribution of 
the drug solution, usually keeping the cooker and cotton 
used to share drugs. The soaked filter and the drug resi-
due left in the cooker can be later re-used adding a little 
bit of water for another shot. Usually, this role is occu-
pied by the user that contributed the most to the caballo. 
These roles are not static, it is possible for one user to be 
a primary partner in one caballo but engage in another 
drug sharing arrangement later on, either with the same 
partner or a different one, without being in charge of the 
process.
In addition, partners might follow different strategies 
while seeking to jointly acquire and use drugs. “Fixers” do 
caballo with a limited number of trusted injection part-
ners in their network, usually kin, or others with whom 
they have close relationships, from school age friends, 
to neighbors or those with whom they have shared 
drugs extensively in the past. By minimizing the num-
ber of partners and routinizing sharing expectations, this 
strategy ensures access to resources while limiting the 
potential problems associated with doing caballo with 
strangers. Other PWID take on the role of “maximizers,” 
entering into caballo with as many partners as possible, 
increasing their opportunities to access drugs by multi-
plying potential partners. Sometimes maximizers only 
know their caballo partners because they have seen them 
around, in Puntos, or shooting galleries, or because they 
have done a caballo in the past. The downside is that this 
choice also increases the potential problems associated 
with the transaction—robbery, cheating, hoarding.
Yet, neither of these are fixed strategies. A PWID might 
have been a maximizer but, over time, begun doing 
caballo with a limited number of partners, and the oppo-
site also happens. Jail, drug treatment, quitting drug use, 
and migration can all affect a person’s social networks 
and their ability to engage in caballo. Of course, this is 
only an approximate typology, and some users are neither 
“fixers” nor “maximizers” but operate in between these 
extremes.
Whether users might be primary partner or not, or 
rely on a “fixer” or a “maximizer” strategy, they all seek 
in their interactions some kind of fair play, adhering to 
the norms that regulate drug sharing in the community. 
Bebe, in his late 30 s, washes cars at a local gas station in 
addition to taking turns as a drug dealer in the only drug 
selling spot in town. He explains the need for reciprocity:
“I tend to avoid caballo, if I have all the money I need 
for my dose I get the drug and I get your money and even 
if you don’t have enough, I share with you because I know 
what it is to be ‘sick.’ How much do you have, I would ask? 
Four dollars [an insufficient amount for a 50/50 caballo]. 
Fine! Let’s go! and we share. But then I remember that in 
other occasions it was me that had only four bucks and I 
were really sick and he had his full dose and he decided 
not to help me out, leaving me sick to fend for myself. I 
still decided to help him but I tell him right away: ‘see, 
before you told me you couldn’t help me because you had 
enough for yourself and now you are desperate, see how 
the world is round? Yesterday it was me [that needed] 
and today it’s you. Come here, I’ll fix it!’”.
Caballo partners who consistently demand more than 
their fair share are labeled “problematic” and tend to be 
excluded. “Tricksters” are also avoided. According to par-
ticipants, tricks are very common among PWID, such as 
pocketing the money that participants have pooled to do 
caballo. This is viewed very negatively, not only because 
it causes a lack of trust among partners but also because 
it deprives users of the “cure” they need, forcing them to 
hustle for money again before they can have their dose. 
Tampering with “bags,” for example by taking a cut, is 
also negatively viewed but is judged less severely than 
the first situation. Participants also worry about others 
pulling a “water shoot,” a trick in which an injector uses 
deception to substitute drugs with water. A similar and 
more frequent trick involves placing not one but two cot-
ton balls in the cooker, hiding the one used to filter the 
drug under the finger holding the cooker, and leaving the 
other with only a trace of drug for the other injector to 
use. Personality issues and past disagreements also play 
a role in selecting potential partners. Those users with 
more social connections will be able to find more suit-
able partners for a caballo while being able to reject those 
partners deemed less desirable. The reverse is also true: 
those users with fewer social connections might not have 
as many options. Caballo partnerships are often shaped 
by asymmetric dynamics involving gender and other 
forms of power disparities among prospective members. 
These in turn affect risk taking and drug related harms. 
Caballo partners try to manage HIV/HCV by serosorting, 
but most assume that there is no point in asking about 
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their partners’ HIV status, because “they will lie to you.” 
Perhaps because they are in a more vulnerable position, 
women tend to ask their injection partners about their 
HCV status more often than men do. Women are also 
more likely to avoid entering in a caballo with somebody 
if they know the prospective partner has a positive status.
Discussion
This study outlines how the social practice of caballo 
has contributed to the production of an HCV epidemic 
among PWID in rural Puerto Rico. Results show that 
84.84% tested positive reactive to HCV, a result that has 
been confirmed by other epidemiological surveys in the 
area [43]. PWID tend to avoid direct sharing of syringes; 
only 7.14% reported having used a needle after somebody 
else had employed it, and 84.62% used a sterile needle the 
last time they used drugs with somebody. On the other 
hand, participants often engaged in indirect sharing: 
71.43% divided drugs with a cooker or cotton that had 
been used by somebody else, and 32.14% divided drugs 
with a syringe that had been used by somebody else. 
These forms of indirect sharing are linked to the prac-
tice of caballo and the need to divide up jointly acquired 
drugs, which in turn increases the risk of HCV among 
this population. While PWID in our study tend to avoid 
direct sharing, indirect sharing is driven by the mode of 
drug acquisition, drug packaging and pricing, a reliance 
on speedball, the need to avoid heroin withdrawal, and 
a strict drug policy that encourage users to carry small 
amounts of illicit substances, among other factors.
The finding that participants attempt to manage HIV/
HCV transmission risk during caballo by serosorting has 
been replicated in other studies of PWID [44–46]. How-
ever, the epidemic levels of HCV in this population sug-
gest that this strategy has serious limitations and that 
individual behaviors alone are insufficient to curb HCV 
transmission. Findings illustrate the need to understand 
social epidemics such as HCV among PWID, leaving 
behind individual-centered models prevalent in public 
health. Decades of ethnographic studies with this popula-
tion have shown that what appears to be the product of 
individual behaviors is better comprehended as a result 
of the particular social contexts in which PWID live and 
make decisions about risk [47–56]. Moving beyond pub-
lic health’s emphasis on individual behaviors, the notions 
of “risk environment” [57] and “syndemics” [58] have 
recently been used to analyze the interplay of micro-level 
dynamics and larger structural forces in accounting for 
risk outcomes. While both approaches share some fea-
tures, Rhodes (2009) suggests that a risk-environment 
approach—combining insights from political economy, 
social epidemiology, and the sociology of health—can 
be productive for understanding how the relationship 
between individuals and environment can produce drug 
harms, thus contributing to a social science of “harm 
reduction.” [59].
Our findings show that poverty and economic dispos-
session have been found to be an important driver of 
indirect sharing among PWID. High frequency users 
might spend $100 or even more a day, not an insignifi-
cant sum considering that Puerto Rico has a per capita 
income more than half of the poorest US States like Mis-
souri or Mississippi [60]. The same relationship between 
poverty and drug sharing has been replicated in numer-
ous studies [27, 31, 61]. In a study of homeless PWID in 
San Francisco Bourgeois (1997) finds that if users cannot 
afford their dose in full, indirect sharing allows users to 
regulate their dose intake in order to minimize the risk 
of experience heroin withdrawal, with some participants 
using half or even a third of a bag each time. In turn, 
using small doses encourages higher frequency of drug 
injection, making drug sharing more likely.
Our findings have shown that roles within drug shar-
ing arrangements are not fixed. This aspect has been 
documented also by Finlinson [30] suggesting that roles 
change within the process of acquiring and dividing up 
drugs. According to this author, a primary partner in 
charge of dividing up the drug solution using their own 
equipment, might become a secondary partner receiving 
a drug solution that has been divided using up somebody 
else’s equipment in another caballo arrangement. These 
practices facilitate the transmission of HCV within a 
population, complicating harm reduction efforts.
One of the most distinctive features of indirect shar-
ing in our study is that the drug preparation is usually 
loaded from the cooker using a single syringe, and then 
distributed to the injecting partners through backload-
ing. While indirect sharing offers a fair method for equi-
table distribution [62], participants in our study do not 
seem to favor drawing the drug solution directly from the 
cooker, because of the perception that it makes it harder 
to ensure an equal share of the drug. It is possible that 
this preference might be driven by a lack of trust among 
injection partners and that in different social contexts, 
other ways of dividing up the drug solution might be 
preferable. A study of Puerto Rican PWID in New York 
and Puerto Rico show that PWID in New York City take 
turns to draw the drug solution from the cooker while 
those on the Island distributed it through backloading as 
well as taking turns [63]. The fact that our findings cor-
respond not to metropolitan San Juan, but rural Puerto 
Rico might account for extensive use of backloading. 
As other authors have shown, the joint acquisition and 
use of drugs appear to be shaped by particular cultural 
norms, which in turn are an adaptive response to a par-
ticular risk environment [64].
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Examining the social context in which PWID use 
drugs and make decisions about risk is critical for the 
successful adoption of harm reduction strategies to 
reduce HCV [65–68]. While harm reduction policies 
that emphasize the distribution of injection equip-
ment are a valuable component in syringe exchange 
programs, findings suggest that preventing the shar-
ing drug preparation equipment while sharing drugs 
might be more complex that behavioral health mod-
els suggests [69]. Indirect sharing occurs not because 
PWID lack information about HCV risk or do not 
possess knowledge about safe injection practices. This 
perspective has been criticized for blaming the victim 
[70] while obscuring the role of social and risk environ-
ments in shaping drug sharing arrangements [71, 72].
In addition, local implementation of effective harm 
reduction recommendations regarding HCV transmis-
sion among PWID is hampered by larger political and 
socio economic processes such as the Colonial status 
of Puerto Rico that deprives the Island of the resources 
it needs to tackle an HCV epidemic, while enacting an 
aggressive version of the war on drugs and subsequent 
incarceration that furthers the impact of HCV within 
its population [73]. Furthermore, the subjection to US 
patent laws and drug pricing ensures that despite the 
fact that a new HCV treatment is available (in the form 
of a three-month-long direct-acting antiviral regimen), 
the cost of that treatment is approximately $50,000. In 
the continental US, the cost of this treatment is cov-
ered by most private insurers or by Medicare/Medic-
aid; in Puerto Rico, few PWID have access to private 
insurance, and HCV treatment is not covered by La 
Reforma, a local version of Medicare/Medicaid for 
HIV-negative individuals who constitute the majority 
of the PWID population [74]. The extremely low HCV 
coverage among PWID [75] continues to fuel the epi-
demic as HCV-negative users are more likely to enter 
caballo arrangements with somebody infected by the 
virus. Expanded HCV treatment coverage would not 
only reduce the incidence of HCV among this popula-
tion but also would contribute to provide certain meas-
ure of “herd immunity” protecting those that are HCV 
negative [76].
Similarly, access to harm-reduction-based interven-
tions such as medically assisted treatment and syringe 
exchange provision have been shown to be protective 
against HCV transmission [77–83]. Unfortunately, these 
resources are severely lacking in Puerto Rico, particu-
larly in rural areas [84]. A recent study showed that rural 
PWID have less access to syringe exchange in rural areas 
than those in urban settings, although both have had to 
resort to acquiring syringes from drug stores, peers, and 
drug dealers [85].
Understanding the social factors behind the HCV 
epidemic in Puerto Rico has a renewed urgency. As the 
Island was starting to recover from the aftermath of Hur-
ricane Maria in September 2017 it was hit by the arrival 
of Covid-19, a pandemic with an epicenter in Wuhan 
China that has currently stricken most of the world. 
While the lasting effects of Covid-19 are not yet well 
known, it is likely the pandemic will reinforce the dev-
astating effects of hurricane Maria which furthered a 
protracted economic crisis on the Island, while exposing 
deep political corruption and mismanagement practices, 
[86, 87] severely affecting the provision of health services 
PWID rely on, like Medically Assisted Treatment and 
Syringe Exchange Providers, leading the way to the wors-
ening of an already existing HCV epidemic.
Increasingly, harm reduction programs will need to 
consider the impact of large-scale natural disasters, or 
pandemic events, and its effects on the risk environment 
of PWID, already afflicted by severe forms of poverty, 
social suffering, and structural violence [88].
One limitation of this study is that findings are based 
on a sample that is overwhelmingly male. While this dis-
tribution mirrors not only the composition of the parent 
study but also of other studies of PWID in Puerto Rico 
that seem to be gendered, the relative lack of female par-
ticipants raises questions about how gender dynamics 
and power imbalances might shape drug sharing arrange-
ments among PWID in rural Puerto Rico. More research 
is needed to explore this issue. We believe that despite 
this limitation, the study of the social organization of 
drug sharing arrangements makes an important con-
tribution to the understanding of HCV risk among this 
population.
Conclusions
This study shows that drug sharing plays an important 
role in the HCV transmission among PWID in rural 
Puerto Rico. While participants avoided direct sharing of 
syringes, they were forced to share the cooker and cotton 
used to divide and inject the drug solution. Drug sharing 
occurs not only within the joint acquisition and use of 
injection drugs, but in a particular risk environment that 
contributes to HCV risk. Poverty, drug packaging and 
pricing, a reliance on speedball, the need to avoid heroin 
withdrawal, and a strict drug policy that encourage users 
to carry small amounts of illicit substances, among other 
factors fuels the HCV transmission. This finding compli-
cates harm reduction interventions based on the distri-
bution of injection equipment or information about safe 
injection practices alone, suggesting that preventing indi-
rect sharing practices should consider the social context 
in which PWID acquire and use drugs.
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